{
    "2021-12-21": [
        [
            {
                "time": "2021-12-01",
                "original_text": "U.S. administers 497.4 mln doses of COVID-19 vaccines - CDC",
                "features": {
                    "keywords": [
                        "vaccines",
                        "CDC",
                        "doses"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-02",
                "original_text": "Israel to Offer Fourth Shots; N.Y. Cancels Exams: Virus Update",
                "features": {
                    "keywords": [
                        "Israel",
                        "Fourth Shots",
                        "Virus Update"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-03",
                "original_text": "AbbVie Stock Retakes Its 50-Day Line On Bullish Earnings — Is It A Buy Right Now?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Stock",
                        "50-Day Line",
                        "Bullish Earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-04",
                "original_text": "FDA Could Authorize Covid Pills This Week — But Pfizer, Merck Stocks Fall",
                "features": {
                    "keywords": [
                        "FDA",
                        "Covid Pills",
                        "Pfizer",
                        "Merck"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-05",
                "original_text": "Is Pfizer Stock A Buy As The FDA Mulls Its Covid Pill Amid Omicron's Spread?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Stock",
                        "FDA",
                        "Covid Pill",
                        "Omicron"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-06",
                "original_text": "Pfizer's Duchenne Gene Therapy Trial Put On FDA Hold After Patient Death",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Duchenne",
                        "Gene Therapy",
                        "FDA Hold",
                        "Patient Death"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-07",
                "original_text": "Broadway League president on Omicron spike: 'We don’t anticipate being shut down at any time soon'",
                "features": {
                    "keywords": [
                        "Broadway",
                        "Omicron",
                        "spike",
                        "shut down"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "entertainment"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-08",
                "original_text": "UPDATE 1-Pardes to go public, says COVID-19 antiviral pill does not need booster",
                "features": {
                    "keywords": [
                        "Pardes",
                        "public",
                        "COVID-19",
                        "antiviral pill",
                        "booster"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-09",
                "original_text": "Novavax CEO: 'We will be filing within the next few days' with FDA",
                "features": {
                    "keywords": [
                        "Novavax",
                        "CEO",
                        "filing",
                        "FDA"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-10",
                "original_text": "Five-Year Follow-Up Data Show Pfizer's Tafamidis Cuts Risk of Mortality by 41% In Cardiomyopathy Patients",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Tafamidis",
                        "Mortality",
                        "Cardiomyopathy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}